Population-level cohorts now combine genetic data with whole-body, multimodal imaging. The article reported that this combination permits mapping the genetic architecture of the brain within its broader bodily context. Investigators described how early imaging genetics largely targeted single organs—especially the brain—while separate efforts addressed heart, skeleton and other organ systems. The review argued that strong physiological interactions and high rates of multimorbidity between brain and systemic diseases require a more integrated, brain-centred, multi-organ approach.
The authors illustrated the conceptual components of this field in a schematic (Fig. 1). The figure links data acquisition, cross-organ phenotyping, statistical genetics and downstream validation. The review emphasized that coordinated datasets, standardized imaging phenotypes and interdisciplinary analysis are necessary to reveal distributed genetic architectures that span organs.
Large-scale population cohorts underpin the work. The article cited landmark studies such as UK Biobank-based genome-wide association analyses of brain imaging phenotypes and work mapping white matter microstructure genetics. Cardiac–brain and eye–brain imaging genetics efforts were presented as foundational resources that demonstrate cross-organ genetic correlations. The review included a figure summarizing available data resources (Fig. 2) and noted that multimodal imaging across heart, retina, liver and skeleton can be combined with genetic assays to extend discovery beyond single-organ studies.
The authors reported that accessible peripheral imaging—retinal imaging, for example—can serve as a proxy for brain biology in some contexts. They also referenced studies demonstrating heart–brain and heart–liver connections using multi-organ imaging phenotypes drawn from large cohorts.
Data indicated that genetic determinants of neurological and neuropsychiatric conditions are intertwined with imaging phenotypes from multiple organs. The review summarized evidence of shared genomic loci and colocalized candidate causal variants that connect peripheral organ imaging traits to major brain disorders. Specific disorders mentioned in the article included Alzheimer disease, stroke and schizophrenia.
Authors pointed to Mendelian randomization studies that infer potentially causal pathways linking body imaging phenotypes with neurological outcomes. The review cited work that integrated imaging and clinical data to infer multi-organ genetic connections through Mendelian randomization, demonstrating how epidemiological genetics methods can suggest directional relationships between organs and brain disease risk.
The article proposed a structured analytical workflow to move beyond mere statistical association. The three-step approach includes: nomination of causal genes at associated loci, construction of organ-enriched network modules that contextualize those genes biologically, and cross-field validation to test mechanistic hypotheses across datasets and experimental modalities. The review included an analytical pipeline figure (Fig. 3) illustrating this progression from gene-level signals to organ-specific networks and validation steps.
Investigators reported that this pipeline helps to prioritize putative biology for follow-up functional studies and clinical investigation. They stressed the need for interdisciplinary teams to interpret network modules that span molecular genetics, imaging phenotypes and organ physiology.
The review traced how brain–body imaging genetics findings are beginning to reshape clinical thinking. It referenced clinical practice guidance addressing brain–heart multimorbidity and highlighted research showing heart–brain–liver axes in population cohorts. Authors argued that imaging genetics can inform risk stratification, biomarker development and potentially new targets for intervention that cross organ boundaries.
The article noted the challenge posed by multimorbidity and sexual dimorphism in some neurological conditions, citing work that implicates brain–body mechanisms in disease differences between sexes. The authors suggested clinical translation will require incorporating multi-organ biology into guidelines and care pathways.
Authors outlined a roadmap for embedding agentic AI systems as collaborators in scientific workflows. The review described agentic AI co-scientists as tools that can support cross-disciplinary discovery, streamline large-scale data integration and operate as part of a collaborative infrastructure for the field (Fig. 4). The article argued these systems will be essential both for individual research groups and for scaling community-wide, integrative analysis.
The previewed content did not provide technical specifications of such systems or implementation details. The authors presented a conceptual roadmap rather than operational protocols.
The preview indicates the review synthesizes published large-cohort studies and conceptual frameworks but does not report new primary experimental results within the previewed text. The source did not report detailed methods, parameter settings or trial-style endpoints in this preview. The authors acknowledged remaining gaps: the need for broader data sharing, standardized multi-organ phenotype definitions, deeper mechanistic follow-up on nominated causal genes and cross-population validation of genetic findings. They also noted that operationalizing agentic AI co-scientists will require technical, ethical and governance work that extends beyond the scope of the review.
Access to the full article is available through institutional subscription or purchase; additional methodological and technical detail reported in the full text was not included in the preview content provided here.